Genome Features and AntiSMASH Analysis of an Endophytic Strain Fusarium sp. R1

Yuanyuan Liu1, Meijie Xu1, Yuqi Tang1

  • 1School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.

Metabolites
|June 23, 2022
PubMed

Insights

Endophytic fungi, like Fusarium sp. R1, are rich sources of therapeutic biomolecules. Genome analysis revealed 37 gene clusters for secondary metabolite biosynthesis, promoting new drug discovery.

Area of Science:

  • Microbiology
  • Genomics
  • Biotechnology

Background:

  • Endophytic fungi, particularly Fusarium strains, are significant sources of bioactive secondary metabolites (SMs) with therapeutic potential.
  • Investigating these fungi aids in understanding plant-microbe interactions and discovering novel compounds.

Purpose of the Study:

  • To comprehensively analyze the genome of endophytic Fusarium sp. R1 for SM biosynthetic gene clusters.
  • To identify potential novel bioactive SMs through in-depth bioinformatic analysis.

Main Methods:

  • Whole-genome sequencing of Fusarium sp. R1.
  • Bioinformatic analysis including antiSMASH annotation, gene prediction, and functional annotation using multiple databases (Nr, Nt, Swiss-Prot, GO, KEGG, COG, PHI, CAZy).

Main Results:

  • The Fusarium sp. R1 genome is 51.8 Mb with 19,333 predicted protein-coding genes.
  • Identified 37 SM biosynthetic gene clusters (BGCs), including NRPSs, PKSs, terpene synthases, and hybrid clusters.
  • Genome assembly resulted in 542 contigs with an N50 scaffold length of 3.21 Mb and 50.4% GC content.

Conclusions:

  • The genomic data provides a foundation for understanding Fusarium SM biosynthesis.
  • Strain R1 harbors a rich repertoire of BGCs, highlighting its potential for discovering new therapeutic SMs via gene mining strategies.

Related Concept Videos